{
    "title": "109_s2255",
    "content": "The Act titled \"Medicare Drug Formulary Protection Act\" allows for the removal of covered Part D drugs from the prescription drug plan formulary. The Medicare Drug Formulary Protection Act prohibits the removal of covered Part D drugs from the prescription drug plan formulary starting in 2006. The Medicare Drug Formulary Protection Act prohibits restrictions on drug coverage, except for new therapeutic uses and newly covered Part D drugs, with exceptions for newly enrolled individuals. The Medicare Drug Formulary Protection Act prohibits restrictions on drug coverage for newly enrolled individuals, preventing the removal of covered Part D drugs or limitations on their coverage. The Medicare Drug Formulary Protection Act prevents restrictions on drug coverage for newly enrolled individuals, allowing coverage of covered Part D drugs without limitations until December 31 of the following plan year, with exceptions for new therapeutic uses and newly covered drugs. The Medicare Drug Formulary Protection Act prevents restrictions on drug coverage for newly enrolled individuals, allowing coverage of covered Part D drugs without limitations until December 31 of the following plan year. This includes generic drugs approved under section 505(j) of the Food and Drug Cosmetic Act, brand name drugs going off-patent, and drugs with clinical warnings issued by the Commissioner of Food and Drugs. The Medicare Drug Formulary Protection Act prevents restrictions on drug coverage for newly enrolled individuals, allowing coverage of covered Part D drugs without limitations until December 31 of the following plan year. The Act includes generic drugs approved under section 505(j) of the Food and Drug Cosmetic Act, brand name drugs going off-patent, and drugs with clinical warnings issued by the Commissioner of Food and Drugs. The Act also requires the PDP sponsor of a prescription drug plan to provide notice of any removal or change in formulary or coverage limitations to the Secretary, affected enrollees, physicians, pharmacies, and pharmacists. The Medicare Drug Formulary Protection Act requires PDP sponsors to provide annual notice of changes in formulary or coverage limitations to enrollees during the coordinated election period for the upcoming plan year. This amendment applies to annual coordinated election periods after the enactment of the Act."
}